“The team focused on cell and gene therapy at ADVI has the expertise that is required and necessary to understand the nuances of bringing products to market.”
Successful cell or gene therapy coverage and reimbursement requires a nuanced, multidisciplinary approach. It also requires deep knowledge in policy, pricing, and access – oftentimes alongside the right partner.
ADVI Health is a trailblazer with critical commercial launch preparation for cell and gene therapies that help treat, prevent, or cure a wide array of untreatable and difficult-to-treat diseases. We help our clients navigate the federal and state policy landscape, highlight unique value drivers, and advocate to critical stakeholders across the healthcare landscape and pride ourselves in the ability to achieve positive results.
We are your go-to partner for strategy, policy updates, data analytics and value economics in cell and gene therapies, rare and ultra-rare diseases, and oncology therapeutics, devices, and diagnostics.
Explore the latest resources and up-to-date information on cell and gene, implications for the industry, and insights on recent updates.
Latest News
“Things are moving very quickly in cell and gene therapy, but ultimately that is a good thing. Our job is to find solutions and get the right people in the right places to get products in position for commercialization success.”
Alicia Silver, MPP, Director, Market Access, Cell and Gene Therapy
Seize The Opportunity
Submit an RFP
Submit an RFP and let’s determine how our team of experts can support your business.
Market Access
Mary Roberts, MPH
Senior Vice President, Market Access Strategy
Yana
Volman
Head of Market Access Biopharma 
Michael
Barlow
Senior Advisor 
Louis Jacques, MD
Senior Advisor
Michael Kolodziej, MD, FACP
Senior Advisor
Norris Turner, PharmD, PhD
Senior Advisor
Shefali Shah, MPH
Senior Advisor
Sherie Smalley, MD
Senior Advisor
Samantha Freeze, MS, CGC
Director
Alicia Silver, MPP
Director
Kalli
Glanz
Senior Manager 